SG Americas Securities LLC Decreases Position in AdaptHealth Corp. (NASDAQ:AHCO)

SG Americas Securities LLC decreased its position in AdaptHealth Corp. (NASDAQ:AHCO) by 25.2% during the fourth quarter, Holdings Channel.com reports. The fund owned 39,346 shares of the company’s stock after selling 13,249 shares during the quarter. SG Americas Securities LLC’s holdings in AdaptHealth were worth $375,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of the company. Intech Investment Management LLC increased its position in shares of AdaptHealth by 223.2% during the third quarter. Intech Investment Management LLC now owns 59,650 shares of the company’s stock valued at $670,000 after buying an additional 41,196 shares during the period. Victory Capital Management Inc. lifted its stake in shares of AdaptHealth by 727.4% in the third quarter. Victory Capital Management Inc. now owns 141,507 shares of the company’s stock worth $1,589,000 after buying an additional 124,404 shares in the last quarter. Barclays PLC lifted its stake in shares of AdaptHealth by 361.3% in the third quarter. Barclays PLC now owns 181,240 shares of the company’s stock worth $2,034,000 after buying an additional 141,949 shares in the last quarter. Royce & Associates LP lifted its stake in shares of AdaptHealth by 13.5% in the third quarter. Royce & Associates LP now owns 777,405 shares of the company’s stock worth $8,730,000 after buying an additional 92,740 shares in the last quarter. Finally, Principal Financial Group Inc. raised its holdings in shares of AdaptHealth by 39.7% during the third quarter. Principal Financial Group Inc. now owns 543,744 shares of the company’s stock valued at $6,106,000 after purchasing an additional 154,434 shares during the last quarter. Hedge funds and other institutional investors own 82.67% of the company’s stock.

AdaptHealth Stock Down 5.4 %

NASDAQ:AHCO opened at $10.24 on Tuesday. AdaptHealth Corp. has a fifty-two week low of $6.91 and a fifty-two week high of $11.90. The stock has a market capitalization of $1.38 billion, a P/E ratio of -6.21, a P/E/G ratio of 1.38 and a beta of 1.09. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24. The company’s 50-day simple moving average is $10.02 and its 200-day simple moving average is $10.37.

AdaptHealth (NASDAQ:AHCO) last released its earnings results on Tuesday, November 5th. The company reported $0.15 EPS for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.02). AdaptHealth had a positive return on equity of 9.62% and a negative net margin of 6.57%. The company had revenue of $805.90 million during the quarter, compared to analyst estimates of $809.32 million. During the same quarter last year, the business earned $0.19 earnings per share. The firm’s revenue for the quarter was up .2% on a year-over-year basis. On average, equities analysts anticipate that AdaptHealth Corp. will post 0.88 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

AHCO has been the subject of several research reports. Canaccord Genuity Group decreased their price objective on shares of AdaptHealth from $14.00 to $13.00 and set a “buy” rating for the company in a report on Wednesday, November 6th. Royal Bank of Canada reduced their price objective on shares of AdaptHealth from $13.00 to $11.00 and set an “outperform” rating for the company in a research note on Tuesday, November 19th. Robert W. Baird dropped their target price on shares of AdaptHealth from $16.00 to $14.00 and set an “outperform” rating for the company in a research report on Wednesday, November 6th. UBS Group lowered their price objective on shares of AdaptHealth from $13.00 to $12.00 and set a “buy” rating for the company in a research report on Wednesday, November 6th. Finally, Truist Financial lowered their target price on shares of AdaptHealth from $13.00 to $12.00 and set a “buy” rating for the company in a report on Friday, November 15th. Five investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, AdaptHealth has an average rating of “Buy” and a consensus price target of $12.40.

AdaptHealth Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.